Equities research analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research note issued to investors on Friday. The firm set a “hold” rating on the stock.
China Pharma Price Performance
CPHI stock opened at $0.21 on Friday. The firm has a 50 day moving average of $0.20 and a 200 day moving average of $0.22. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. China Pharma has a 52 week low of $0.13 and a 52 week high of $0.60.
About China Pharma
See Also
- Five stocks we like better than China Pharma
- Basic Materials Stocks Investing
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Differences Between Momentum Investing and Long Term Investing
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
